Colony Group’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-735
Closed -$44K – 771
2023
Q1
$44K Hold
735
– – ﹤0.01% 775
2022
Q4
$68K Hold
735
– – ﹤0.01% 817
2022
Q3
$88K Hold
735
– – ﹤0.01% 752
2022
Q2
$57K Hold
735
– – ﹤0.01% 805
2022
Q1
$114K Hold
735
– – ﹤0.01% 824
2021
Q4
$177K Hold
735
– – ﹤0.01% 780
2021
Q3
$316K Hold
735
– – 0.01% 672
2021
Q2
$401K Hold
735
– – 0.01% 580
2021
Q1
$287K Hold
735
– – 0.01% 651
2020
Q4
$315K Hold
735
– – 0.01% 601
2020
Q3
$626K Hold
735
– – 0.02% 435
2020
Q2
$608K Hold
735
– – 0.02% 423
2020
Q1
$273K Hold
735
– – 0.01% 568
2019
Q4
$280K Buy
+735
New +$480K 0.01% 651

Other funds holding KRSA

Colony Group's KRSA Position: Q2 2023 in Review

Colony Group sold out of Korsana Biosciences (KRSA) in Q2 2023, closing a stake of 735 shares — an estimated $44K sold.

Colony Group first reported a position in KRSA in Q4 2019 and held it in 14 quarters. The position peaked at $626K in Q3 2020. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

  • Colony Group reported no remaining Korsana Biosciences position as of Q2 2023 after selling out during the quarter.
  • Colony Group sold 735 Korsana Biosciences shares in Q2 2023, an estimated $44K.
  • Colony Group first reported a position in Korsana Biosciences in Q4 2019 and held it in 14 quarters.
  • Colony Group's Korsana Biosciences position peaked at $626K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences as of Q2 2023.

Based on Colony Group's 13F filing for Q2 2023, filed 15 Aug 2023.